Company Profile

Company Description

Kymera Therapeutics is a biopharmaceutical firm focused on developing novel small molecule therapies using targeted protein degradation. Leveraging its proprietary Pegasus platform, the company aims to address previously undruggable targets in immuno-oncology, inflammation, and other therapeutic areas. Its innovative approach harnesses the body's natural protein disposal system to degrade disease-causing proteins, offering potential breakthroughs for patients with challenging conditions. The company collaborates with industry leaders to advance its pipeline of transformative medicines.